Studies of serum-free medium for the generation of lymphokine-activated killer cells.
We examined a serum-free medium (designated as TYI 101) for the generation of lymphokine-activated killer (LAK) cells from human lymphocytes, regional lymph node lymphocytes (RLNL) and peripheral blood lymphocytes (PBL). TYI 101 medium consisted of, in addition to nutrient mixture, transferrin, insulin, fetuin, sodium selenite, 2-mercaptoethanol, o-phosphorylethanolamine, chick egg yolk and porcine kidney extract. These hormones were effective for supporting RLNL proliferation as assessed by (3H)-thymidine uptake. When human lymphocytes from two different sources were cultivated with recombinant interleukin 2 (rIL-2) in TYI 101 medium, LAK activity was generated. In cultures of PBL from a healthy donor, LAK cells were generated in TYI 101 medium as efficiently as in RPMI 1640 medium supplemented with 10% human AB-type serum (RPMI-AB). In cultures of RLNL from lung cancer patients, LAK activity obtained in TYI 101 medium was about sixty-five percent of that in RPMI-AB. However, the addition of a small amount of AB-type serum improved the generation of LAK activity, LAK cell expansion, and cell viability in TYI 101 medium. We conclude that TYI 101 medium can be used for the generation of LAK cells from human lymph node lymphocytes with supplementation of none or only a reduced amount of human serum.
Department of Immunology, Kyushu University, Fukuoka, Japan.
M
M
Togami
K
K
Yasumoto
T
T
Yano
T
T
Ishida
G
G
Kimura
K
K
Sugimachi
K
K
Nomoto
D000818:Animals; D001769:Blood; D002455:Cell Division; D002478:Cells, Cultured; D003470:Culture Media; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000166:cytology*; D007700:Kinetics; D007963:Leukocytes, Mononuclear; D008198:Lymph Nodes / Q000166:cytology; D008875:Middle Aged
D003470:Culture Media